Key Points
-
Billionaire investor Stanley Druckenmiller liquidated his entire stake in Nvidia and Palantir Technologies during Q3 2024.
-
Since early 2023, Nvidia’s market cap reached $5 trillion, while Palantir’s stock has surged over 2,900%.
-
Druckenmiller has consistently bought shares of Teva Pharmaceutical Industries, totaling 16.6 million shares across five quarters, as Teva’s stock climbed 191% in 2024.
Stanley Druckenmiller, head of the Duquesne Family Office, divested his holdings in Nvidia (214,060 shares) and Palantir (769,965 shares) in Q3 2024, exiting these AI-centric stocks that have seen explosive growth this year. Nvidia became the first company to hit a $5 trillion market cap, while Palantir’s value skyrocketed over 2,900% in recent months.
On the other hand, Druckenmiller has notably boosted his investment in Teva Pharmaceutical Industries, purchasing 16.6 million shares since Q3 2024. Teva’s stock has risen 191% this year, aided by resolutions to legal challenges and a strategic focus on brand-name drugs, improving its pricing power. As of Q3 2025, Teva has become the third-largest holding in Duquesne’s nearly $4.1 billion portfolio.
